Trials / Terminated
TerminatedNCT03123159
Clinical Performance Evaluation of DxN HBV Assay
Clinical Utility of the DxN HBV Assay as an Aid in the Management of HBV-Infected Individuals Undergoing Antiviral Therapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Beckman Coulter, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The DxN Hepatitis B Virus (HBV) Assay is an in vitro diagnostic assay intended as an aid in the management of HBV-infected individuals undergoing antiviral therapy. The purpose of the study is to establish the clinical performance of the DxN HBV Assay for plasma samples in the intended use population.
Detailed description
Same as brief summary.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | DxN HBV Assay | Molecular diagnostic test to detect Hepatitis B |
Timeline
- Start date
- 2014-05-27
- Primary completion
- 2017-08-30
- Completion
- 2017-08-30
- First posted
- 2017-04-21
- Last updated
- 2018-07-12
Locations
10 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT03123159. Inclusion in this directory is not an endorsement.